Lifespan predicting DNA test to go on sale

By Admin
A revolutionary DNA blood test that can predict how long you will live is due to go on sale in Europe and possibly in America. The blood test will be a...

A revolutionary DNA blood test that can predict how long you will live is due to go on sale in Europe and possibly in America.

The blood test will be available in over-the-counter settings and will cost $700 (£435) when it first goes on sale in Britain later this year.

The test identifies the length of a person’s telomeres which are bits of DNA at the end of the chromosomes.

To read the latest edition of Healthcare Global,
click here
Many people in the US use the internet for medical advice
Twitter is a vital link to patients
iPad 'spinal surgery recovery tracker' is being trialled

Scientists believe that telomeres indicate the speed at which someone ages and those with shorter telomeres tend to die younger than those with long telomeres.

However, critics are branding it controversial and are saying it will open a ‘Pandora’s box’ in which insurance companies will demand a blood test before offering a policy.

Some scientists are also concerned about how people will react if the test delivers bad news, while others are worried it could be used to market fake ‘elixirs of life’.   

A Madrid-based company Life Length has manufactured the test and in an interview Life Length CEO Steve Matlin said the company does not claim the test can predict length of life, it merely just alerts people to high concentrations of short telomeres.

As yet the test is unable to predict the exact amount of months or years a person has left to live although scientists believe telomere testing will become widespread within the next ten years.

Life Length itself is also predicting the demand for the test will be high once they can bring down the price of the test.

Although Life Length is not the only company offering telomere blood tests, they are the only company to be making them available to the public over-the-counter.  


Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma